RVPNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
RETRACTABLE TECHNOLOGIES INC
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$0.58+0.00 (+0.33%)
Close on Oct 19, 2026
- Market cap
- $17.30M
- P/E (TTM)
- –
- Dividend yield
- –
RETRACTABLE TECHNOLOGIES INC revenue by segment
By business segment
| Revenue | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | Q4 23 | Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Single reportable segment | $7.20M | $7.18M | $9.44M | $10.09M | $10.45M | $8.30M | $9.07M | $10.35M | $6.03M | $7.60M | – | – | 100.0% | -31.1% |
| Other international sales | – | – | – | – | – | – | – | – | – | – | $1.54M | $102.56K | – | – |
| North and South America sales (excluding U.S.) | – | – | – | – | – | – | – | – | – | – | $261.88K | $839.73K | – | – |
| U.S. sales (excluding U.S. government) | – | – | – | – | – | – | – | – | – | – | $12.48M | $9.39M | – | – |
By product or service
| Revenue | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | Q4 23 | Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Syringes | $6.25M | $5.80M | $6.17M | $5.85M | $5.93M | $6.96M | $5.69M | $5.17M | $5.49M | $6.38M | $10.58M | $7.35M | 86.8% | +5.4% |
| EasyPoint Needles | $646.42K | $993.21K | $2.91M | $3.85M | $4.20M | $983.52K | $3.10M | $4.86M | $189.28K | $699.90K | $3.13M | $2.57M | 9.0% | -84.6% |
| Blood Collection Products | $295.94K | $374.93K | $350.63K | $372.75K | $302.78K | $343.83K | $281.94K | $298.72K | $333.79K | $511.17K | $577.90K | $390.06K | 4.1% | -2.3% |
| Other Products | $7.71K | $6.99K | $5.35K | $11.46K | $19.13K | $7.68K | $9.07K | $11.42K | $17.39K | $7.98K | $8.75K | $22.62K | 0.1% | -59.7% |
| Licensing fees | $0 | $0 | $0 | $0 | $0 | $0 | – | $38.00K | $90.00K | $99.00K | $778.00K | $0 | 0.0% | – |
By region
| Revenue | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | Q4 23 | Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States | – | – | – | – | – | – | – | $9.63M | $5.01M | $6.64M | – | $9.39M | – | – |
| North and South America (excluding U.S.) | – | – | – | – | – | – | – | $569.97K | $666.28K | $154.63K | – | $839.73K | – | – |
| Other international | – | – | – | – | – | – | – | $148.28K | $349.51K | $803.56K | – | $102.56K | – | – |
From the segment and revenue-disaggregation notes of Retractable Technologies's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.